chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Took bandage off after a week (Sun 5-8-22) started itching.  Next day (Mon 5-9-22) large 3" plus red area and itching.  Next day (Tues 5-10-22) large 3" plus area itching, and now SWOLLEN.
Woke up at 3am on  second morning after vaccine with extreme dizziness and nausea. Continued to have dizziness, nausea, and dry heaves until following day. Could do nothing but sleep. Lightheadedness continued through the next day after that but nausea passed.
Patient was given Hep A peds and she should have received Hep A adult. this makes it ineffective and patient needs an adult dosing to be complete with series.
After 4 days begun to get headaches that are increasingly worse as the days pass. After a week have noticed bouts of vertigo that are getting increasingly worse. The vertigo and headaches have made me nauseous at times.
This spontaneous initial report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. The reporter informed that on an unspecified date the patient was vaccinated with a dose of an improperly stored VARIVAX lot # N008077, with expiration date 09-MAR-2019 (strength, dose, frequency, route of administration were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MRK). No adverse effect was reported. The temperature of excursion was reported as 20.5 degree Fahrenheit (°F). The time frame was reported as 2 hours. There was no previous temperature of excursion reported. There was a digital data logger involved. This is one of several reports received from the same reporter Sender's Comments: US-009507513-1711USA002762: US-009507513-1711USA002761: US-0095075131711USA002444.
I got this one yesterday and I have been sick ever since; I am having an reaction, and then I 'discage' then up and then I open; This is a spontaneous report from a contactable consumer (the patient reported for self). A patient of an unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on 21May2021 (reported as "yesterday") as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had earlier received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), via an unspecified route of administration on an unknown date (Batch/Lot number was ER8731) as dose 1, single for COVID-19 immunization and had no problem. The patient stated, "This is serious, I have just taken a shot yesterday  (not clear) over the place for the COVID Vaccine and I am having an reaction, and then I 'discage' then up and then I open, so what do I do?. I took my second one, the first one was not like this, that was cool and not I got this one yesterday and I have been sick ever since. I am just trying to find out why do I feel like this because my first shot everything was fine, I had no problem (incomplete sentence)." Reason for no lot number: of COVID 19 Vaccine, the patient stated "Oh my first one, this is my first one that I understand it's ER8731, but I can't understand the second whoever wrote this, the lady who gave me the shot." No further probing was done as the consumer was unwilling to share any further information and was not able to understand the call handler. Limited information available over the call. The events were non-serious. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
herpes zoster; post herpetic neuralgia; Information has been received regarding a case in litigation, concerning a patient (pt) of unknown age and gender. The pt's medical history, concurrent conditions and concomitant medications were not provided.   On an unspecified date, the pt was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (dose, route of administration, anatomical location, lot number and expiration date were not provided).  On an unspecified date (reported as "shortly after receiving the vaccine"), the pt suffered herpes zoster and post herpetic neuralgia. As a result of these symptoms, the pt was seen and treated by medical providers and was still under their care. As a direct and proximate result of the vaccine, the pt's symptoms resulted in physical limitations not present prior to using the product, and experienced mental and emotional distress due to resulting physical limitations and seriousness of the condition. The pt suffered serious, severe, progressive, permanent, and incurable personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reported events were not resolved. The events of herpes zoster and post herpetic neuralgia were considered to be related to zoster vaccine live (ZOSTAVAX) by the reporter.   Upon internal review, the events of herpes zoster and post herpetic neuralgia were considered to be disabling.
Chills and severe headache and weakness. Rash below the vaccine site on the left arm. All lasted for 5 days. Took ibuprofen to deal with it. Took it once a day. No fever. Did not go to the doctor
24 hours OBV-HOLD-IV fluids.  Hypotonic hyporesponsive episode. 05/09/2008 MR received for DOS 4/15-16/2008 with D/C DX: Adverse Reaction to Immunizations. Within hours of receiving vaccines pt became pale, lethargic and could not be roused to feed.  PE (+) for lethargy and tachycardia (182 bpm). Improvement noted with IVF bolus.
Headache - took Ibuprofen 400 mgs and Headache did not go away Fatigue - hours after vaccine and has continued  Nausea - occurred 3 days after vaccine
Day after receiving 2 vaccines, pt. had a rapid heart-rate that lasted approx. 1 min. also c/o "hard to get my breath." States she's never noticed this happening before.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 05-NOV-2015, the patient was vaccinated with improperly stored (exposed to the following temperatures and cumulative time frames colder than 36 F: In September 2015, the coldest temperature was 34 F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34 F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34 F for 192 hours, for a total of 1,031.3 hours (43 days)) VAQTA injection, 0.5 ml (lot # L018499, exp. date: 25-FEB-2017) (route and strength unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaint s(PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd vax 21JUN93 & immed following vax devel mild rash; lab eval on 22JUN93 revealed a nl CBC; seen by MD on 25JUN93 due to exacerbation of the sx;
A non-serious spontaneous report of "he got H1N1 and got fever and body aches" has been received from a nurse concerning an eight-year-old male, subsequent to H1N1, intranasal. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received H1N1, intranasal on 23-Oct-2009 for unknown indication. Three days after receiving H1N1, intranasal, the patient developed fever and body aches. Treatment for the events was not provided. The outcome for the reported adverse events is ongoing.
24 hours later she developed R sided facial numbness, that side of her face felt "paralyzed".  She states she has only drooping of her eyelid no other muscle drooping.  Also feels discomfort swallowing.  Sx continue to worsen
got vaccinated for the Covid-19 Vaccine but tested positive after that; got vaccinated for the Covid-19 Vaccine but tested positive after that; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer reported that a patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that someone she knew who got vaccinated for the Covid-19 Vaccine but tested positive after that. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
-Obtained my second vaccine on 9/1/2021 -Flew out on 9/10/2021 -Started noticing unique and concerning symptoms such as; fatigue, hard time breathing but the most concerning was the chest stabs. Overtime, these symptoms continued to get worse which let me to go back in to see the Cardiologist and Primary Care. After blood, work, EKG and an Echocardiogram he diagnosed me with some fluid in the heart and I am currently being treated for "Pericarditis".
"Covid Arm" (red and tender at shot site) for 24 hours; also neck and body aches
Itchy rash; tiredness; Fever; Chills; Body aches; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced itchy rash, tiredness, fever, chills and general body pain. On an unknown date, the outcome of the itchy rash, tiredness, fever, chills and general body pain were unknown.   It was unknown if the reporter considered the itchy rash, tiredness, fever, chills and general body pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The Patient received 1st dose of Shingrix and experienced itchy rash, tiredness, fever, chills and body aches. The patient wanted to know if the second shot was necessary. The caller declined to provide his address or answers any questions related to his adverse event. The caller ended the call abruptly before any questions could be asked.  No Healthcare professional information was provided. The reporter did not consented to follow up.
Patient received vaccine and waited her 15 mins. Patient stated that she went back to work and started to feel bad. Patient came back to the vaccine clinic where she was instructed to sit down. Upon sitting down patients vitals and O2 sat checked and noted to be in normal ranges. WIth an elevated heart rate. Patient was instructed to take some deep breaths. Patient was talking and laughing. Patient given some water and crackers. 5 mins after given food and water patient threw-up the water and crackers. Patient states that her head feels light and dizzy. Patient encouraged to go to hospital seeing that patient stated that symptoms not getting better. Ambulance ride offered and patient refused to go via ambulance. Patient stated that she would go with her emergency contact (Her mom).  Patient's mom called, mom came and picked patient up. Patient instructed to go to ER. Patient verbalized understanding.  Patient called Tuesday morning. Patient states that she is feeling much better. She states that her mom took her to urgent care and it was later determined that the patient was having a panic attack.
pt became pale, dizzy, vomited became urine incontinent; had some stiffness sxs; resolved p/pt vomited;
pt was in clinic 4MAY95 for check-up; dx w/yeast rash on neck & OM but was cleared for vax by MD; pt devel rash on back, arms, & legs about 530-6PM on 4MAY95-no resp distress; dx w/hives; also dx w/acute pharyngitis in ER
Blew my nose on 4/14/21 at 7:30 p.m. only to have my left nostril start bleeding like a faucet.  It continued for approximately 10 minutes until I hacked out what looked like a clot from my throat about the size of a  50 cent piece.  My nose then stopped bleeding and after clearing my throat several times for about 20 minutes, everything is clear. I placed a cold pack on my face for about 20 minutes.  This is definitely an odd thing for me.  I do not smoke and never have.  I felt fine before the nosebleed and feel absolutely fine now, an hour after the event started.  I didn't feel bad during the nosebleed, only scared.
R Hip pain radiating down leg and up spine began 1:30PM date of vaccine, has worsened since then. Managed with heating pad and usual pain medication but is debilitating.
Severe Migraine 10/10  lasting 24 hours (felt like my head was going to explode ice applied to my eyes and next), Nausea, Body aches lasting 24 hours ( could not move without help pain 8/10), congestion, fatigue.
is HPV positive for type 16 and/or 18.; This spontaneous report was received from a consumer referring to her 25-year-old niece. Information regarding concurrent conditions, medical history, drug reactions, allergies and concomitant therapies were not provided.   On an unknown date, when the patient was an adolescent she was vaccinated with 2 or 3 dosed of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) for prophylaxis (lot#, expiration date, dose, route of administrations was not provided).   It was reported that currently, the patient was human papilloma virus positive for type 16 and/or 18. It was reported that final results to confirm were pending. It was unknown if the patient received treatment for the event. The outcome of the event was not reported.   Causality assessment was not provided.
Took 1st vaccine without knowing I was pregnant.  1 week later, had a positive pregnancy test.  GYN/OB office advised me to wait until I was 8 weeks pregnant to have  my first prenatal appointment. On Sept 13th, I found out at MD office, there was no heart beat, only yolk present. Which indicated a miscarriage. I needed and D&E procedure which was performed on 9/23/21.
Left axillary lymphadenopathy started on day 3 (Sat) now still painful and tender, day 4; Left axillary lymphadenopathy started on day 3 (Sat) now still painful and tender, day 4; Dose Number: 1 23Dec2020, Dose Number: 2 10Jan2021; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Jan2021 12:00 (Lot number: EL3249) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LISINOPRIL. Vaccination history included: Bnt162b2 (Dose 1, Single, Batch/Lot No: EL1284, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 23Dec2020, when the patient was 54 years old, for COVID-19 Immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 10Jan2021, described as "Dose Number: 1 23Dec2020, Dose Number: 2 10Jan2021"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 06Nov2021 12:00 and all described as "Left axillary lymphadenopathy started on day 3 (Sat) now still painful and tender, day 4". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of lymphadenopathy, lymph node pain. Additional information: The patient received dose 3 (BOOSTER), single with lot number: EW0173 on 11Nov2021 at 10:00 AM administered in left arm. No other vaccine in four weeks. Other medications in two weeks included lisinopril. No Covid prior vaccination, covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.  Follow-Up (21Mar2022): Follow-up attempts are completed. No further information is expected.  Amendment: This follow-up report is being submitted to allow appropriate reporting to health authorities.
About 2 hours after receiving the vaccine, I started to have kinda like tunnel vision, my ears felt cloggd. Tachycardia, palpitations, nausea/vomitting, extreme Fatigue, weakness, headache, dizziness, and loss of memory. I had  this type of episode 2-3 times over 5 days,  lasting about 20-30 minutes, last one being at work, all of a sudden, same type of episode.  Went to ER after Coworkers stated I was " in coherent " or in and out, my BP upon arrival to er was in the 160's/90's. They ran multiple lab tests, CT head, CXR and ECG.  By the time I was dicharged my BP was normal I believe it was 116/81.  Some side effects like nausea lasted a week, I was given an antinuasea prescription
A couple of weeks after having the vaccine I had stuffiness. I went to an emergency clinic. They did not prescribed any medication or did any tests or give me any treatment.
body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body ache) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body ache) and HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MYALGIA (body ache) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.
Some numbness between her elbow and wrist.She mentioned that someone else also had a similar adverse event; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "Some numbness between her elbow and wrist.She mentioned that someone else also had a similar adverse event".  Additional information: Caller mentioned she already received 4 shot of the Pfizer-BioNTech COVID-19 Vaccine (2 shots for the primary series and 2 booster shots). She recently received the bivalent formulation and 3 days after the injection, she noticed some numbness between her elbow and wrist. She mentioned that someone else also had a similar adverse event and she wanted to know if this had been reported.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This study case was received from the investigator in a trial on 24 May 2013. A 26-year-old male subject was found to have other and unspecified angina pectoris 1 day after receiving the following vaccines on 26 February 2013: an injection of ACAM2000 (lot number, route and site of administration not reported), TYPHIM (lot number, route and site of administration not reported) and Anthrax (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included an abnormal ECG on 27 February 2013 and an abnormal echocardiogram on 05 March 2013. Treatments were not reported. Past medical history included palpitations/pounding heart with exercise, chest pain, abnormal ECG (electrocardiogram), shortness of breath, asthma (include exercise induced) and headaches. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
This spontaneous report as received from a pharmacist via company representative refers to a 12 year old female patient (also reported as the pharmacist's daughter). The patient did not have any pertinent medical history. On an unknown date in October 2013, the patient was vaccinated with a first dose of GARDASIL (route, dose, lot number and expiry date were not reported). On an unknown date in 2013, a couple of weeks later, after administration of GARDASIL the patient developed mononucleosis (disability) with a chronic headache (disability) and fatigue (disability). The pharmacist did not administer GARDASIL again and therapy with GARDASIL was discontinued. The outcome of the events mononucleosis, chronic headache and fatigue were unknown. The events mononucleosis, chronic headache and fatigue led to disability. Additional information has been requested.
Few small red spots on her body; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH MACULAR (non-serious), outcome "unknown", described as "Few small red spots on her body". Therapeutic measures were taken as a result of rash macular.  Additional information: Caller was calling for a patient who received both doses of the Pfizer COVID Vaccine. She mentioned that on her 1st dose, the patient experienced a few small red spots on her body. The 2nd dose, which she received last week, blew her up with a pretty significant rash all over her body that look like underlying diffused erythema with a multiforma look. She mentioned that she was already given steroids at a fairly moderate amount without improvement. She was considering on giving her a high dose of steroids. She was asking if there have been any reports on this and for any input on the situation.  No follow-up attempts are possible. No further information is expected.
Approximately 3 hours after receiving vaccination, heart racing and Blood Pressure high.  Pulse 120 to 184.  Blood Pressure 264/130.  Took 2 Nitroglycerin and baby aspirin.   Went by ambulance to Emergency Room.   Discharged from ER with diagnosis of chest pain per patient.  Was in emergency room for approximately 3 hours once blood pressure and heart rate stable.
TDAP given 9-1-09. On 9-2-09 at 2:30 AM woke up & headache. Headache not relieved & Tylenol or Ibuprofen as reported to me 9/3/09 TC to support physician-orders received to have client take Benadryl 25 50 mg Benadryl q 6 hours, Zantac 50 mg BID.
Pt very fussy, cried for four hours in high pitched cry. Denies fever > 99.5. Called MD at 4 month old shot, MD recommended pt only receive from 4 month shots today and in the future.
welt on her back; This case was reported by a consumer via call center representative and described the occurrence of welts in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (the patient gets approximately 2 shingrix outbreaks per year). Previously administered products included Zostavax (previously received Zostavax).   On 10th January 2020, the patient received Shingrix. On 22nd April 2020, 103 days after receiving Shingrix, the patient experienced welts. On an unknown date, the outcome of the welts was unknown.   It was unknown if the reporter considered the welts to be related to Shingrix.  Additional details were provided as follows: The patient gets approximately 2 shingrix outbreaks per year. The patient had a welt on her back in the same place that she usually gets a shingles outbreak. The reporter consented to follow up.
17 yo emancipated minor, female received 1/2 the correct dose, she received the dose intended for age 6 mo to 11 yo. She was immediately informed and to return to clinic.  Patient declined returning to clinic to receive the second half of the correct dose.